History of EMA
Submitted by Anonymous (not verified) on 28 March 2025 - 13:49
History of EMA
History of EMA
Template for response to list of questions/list of outstanding issues: Quality / Non-clinical / Clinical
Day 80 assessment report - Non-clinical template with guidance Rev. 03.25 - Revamp
Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2012 Positive
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 March 2025
Summary of opinion: Xydalba, 27/03/2025 Positive
Summary of opinion: Flucelvax, 27/03/2025 Positive
Summary of opinion: Opdivo, 27/03/2025 Positive
Summary of opinion: Calquence, 27/03/2025 Positive
Summary of opinion: Tremfya, 27/03/2025 Positive